Endo Health Solutions (NSDQ:ENDP) said it struck an $830 million deal to settle thousands of lawsuits over its American Medical Systems pelvic mesh products.
MassDevice Earnings Roundup
Abiomed reveals HHS probe into provider payments
Weather-induced FDA delay hits Staar Surgical’s bottom line
California-based STAAR Surgical (NSDQ:STAA) swung hard to a 1st-quarter loss after storm-related regulatory delays cost the company its bottom line.
Legal loss pushes NuVasive to Q1 red
NuVasive Inc. (NSDQ:NUVA) swung to a 1st-quarter loss after a jury ruled against it in a trademark infringement battle with NeuroVision, prompting the medical device company to lower its 2014 earnings outlook and investors to pare more than 2% from its share price.
Patent battle takes a chunk out of Varian’s bottom line
Radiosurgery devices maker Varian Medical (NYSE:VAR) posted a tough quarter, with sales up a modest 1.3% and earnings sucked up by legal charges in its 2nd quarter.
Boston Scientific beats estimates with Q1 earnings, but sales miss the mark
AtriCure tops Q1 sales estimates, raises 2014 outlook
Covidien beats The Street by 1¢ in Q2
Listen to Edwards Lifesciences’ Q1 2014 earnings call
Edwards Lifesciences’ Sapien sales grow 11.5% in Q1
Medtech giant Edwards Lifesciences (NYSE:EW) posted Street-beating figures for its 1st quarter, driven largely by growth in its transcatheter heart valves.